3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other hematologic neoplasm
1
Lymphoid
1
Conditions
Brain Neoplasms
3
Parkinson Disease 4, Autosomal Dominant Lewy Body
2
Pain, Postoperative
2
Pain
2
Ovarian Neoplasms
2
Neoplasms
2
Warts
1
Stroke
1
Sepsis
1
Schwannomatosis
1
Prostatic Neoplasms
1
Pleural Effusion
1
Peritoneal Neoplasms
1
Pancreatic Neoplasms
1
Pancreatic Cyst
1
Neuroinflammatory Diseases
1
Neurilemmoma
1
Multiple Myeloma
1
Metastatic Non-Squamous Non-Small Cell Lung Cancer
1
Lymphoma, Non-Hodgkin
1
Lymphoma
1
Leukemia, Lymphocytic, Chronic, B-Cell
1
Hypoxia
1
Hyperthermia
1
Hemorrhage
1
Glycopyrrolate
1
Fallopian Tube Neoplasms
1
Esophageal Squamous Cell Carcinoma
1
Erectile Dysfunction
1
Colorectal Neoplasms
1
Interventions
venetoclax
28
Rituximab
22
ibrutinib
21
acalabrutinib
21
Cyclophosphamide
20
Specimen Handling
18
obinutuzumab
15
Biopsy
14
fludarabine
13
zanubrutinib
10
pirtobrutinib
10
fludarabine phosphate
9
Magnetic Resonance Spectroscopy
8
Bendamustine Hydrochloride
8
idelalisib
6
Whole-Body Irradiation
6
Mycophenolic Acid
6
Lenalidomide
6
CT-P10
6
ARQ531
6
Cyclosporine
5
Sirolimus
4
Peripheral Blood Stem Cell Transplantation
4
pembrolizumab
3
Vincristine
3
Tacrolimus
3
Prednisone
3
Doxorubicin
3
Disulfides
3
Cyclosporins
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Leukemia, Lymphocytic, Chronic, B-Cell
×
Saline Solution
×
90 days
×
Clear all
NCT05645107
2026-04-13
EXCELL
Grifols Therapeutics LLC
Phase 3
Recruiting
386 enrolled